MacKay Memorial Hospital;Goldred Nanobiotech Co., Ltd.
发明人:
申请号：
EP20159206.0
公开号：
EP3698787A1
申请日:
2020.02.25
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed herein is a method for treating an inflammatory disease in a subject, including administering to the subject a therapeutically effective amount of a dihydrolipoic acid (DHLA) coated gold nanocluster about 0.1 to 20 nm in diameter. Also disclosed is a method for reducing the expression of a pro-inflammatory molecule in a cultured cell, including contacting the cultured cell with the said DHLA coated gold nanocluster. Still disclosed is a pharmaceutical composition that includes the present DHLA coated gold nanocluster. The pharmaceutical composition is useful for treating the inflammatory disease in the subject.
